| Brain Mechanism and Intervention of Executive-control Dysfunction Among Substance Dependents (NCT05312359) | Shanghai Mental Health Center | 2022-06-01 |
| Developing a Telehealth Model to Improve Treatment Access for Rural Veterans With Substance Use Disorders (NCT05348317) | VA Office of Research and Development | 2022-05-19 |
| Pre-exposure Prophylaxis (PrEP) for Health (NCT04430257) | Brown University | 2021-09-02 |
| Can The Bridge Transition Opiate Use Disorder Patients in Stable Recovery From Buprenorphine to Naltrexone (NCT03762798) | The Cleveland Clinic | 2018-11-19 |
| Online Cognitive Behavioural Therapy for Addiction: Efficacy and Cost-Effectiveness in a Pragmatic Clinical Trial (NCT03767907) | Centre for Addiction and Mental Health | 2018-10-01 |
| Efficacy of Cognitive Bias Modification in Residential Treatment for Addiction (NCT03000699) | Centre for Addiction and Mental Health | 2017-03-01 |
| Family Engagement, Cross-System Linkage to Substance Use Treatment for Juvenile Probationers -- Phase 3 (NCT03048552) | New York State Psychiatric Institute | 2016-11-17 |
| Trial of a Novel Cognitive-Behavioral Treatment for Posttraumatic Stress and Substance Dependence (NCT02461732) | The University of Texas Health Science Center, Houston | 2014-08-01 |
| Citicoline and Omega-3 Fatty Acid Effects in Veterans With Traumatic Brain Injury (TBI) (NCT01515917) | Deborah Yurgelun-Todd | 2013-11-01 |
| Distress Tolerance Treatment for Substance Users (NCT01741415) | University of South Florida | 2013-05-13 |
| Evaluation of Impulsivity on Cocaine and Crack Addicts (NCT01550887) | Federal University of São Paulo | 2012-04-01 |
| Intervention Targeting Substance Using Older Adults With HIV (NCT01305629) | Hunter College of City University of New York | 2011-06-01 |
| Improving Outcomes in Psychosis Associated With Substance Use Using Aripiprazole (NCT01155544) | Northwell Health | 2011-06-01 |
| Continuing Care Following Drug Abuse Treatment: Linkage With Primary Care (NCT01621711) | Kaiser Permanente | 2011-03-01 |
| fMRI Study of a Dual Process Treatment Protocol With Substance Dependent Adults (NCT01320748) | Inova Health Care Services | 2011-02-01 |
| Effects of Intensive Behavioral Training Program on Impulsivity and Inhibitory Control in Smokers (NCT01314378) | Massachusetts General Hospital | 2011-01-01 |
| Cognitive Remediation and Work Therapy in the Initial Phase of Substance Abuse Treatment (NCT01410110) | Yale University | 2010-12-01 |
| Efficacy Trial of Warrior Check-Up (NCT01128140) | University of Washington | 2010-10-01 |
| A Pilot Clinical Trial of Varenicline as a Treatment for Alcohol Dependence (NCT01011907) | University of California, San Francisco | 2010-01-01 |
| A Dose Ranging Study of Modafinil for Methamphetamine Dependence (NCT00630097) | California Pacific Medical Center Research Institute | 2009-12-01 |
| GSK618334 Repeat Dose Study (NCT01036061) | GlaxoSmithKline | 2009-09-28 |
| Effects of GSK598809 on Brain Activation in Abstinent Alcoholics (NCT00908206) | GlaxoSmithKline | 2009-05-01 |
| Initialization of Methadone in Primary Care, Randomized Intervention Research for Preventing HCV Transmission Practices (NCT00657397) | French National Agency for Research on AIDS and Viral Hepatitis | 2009-01-01 |
| Effects of the D3 Antagonist GSK598809 on Food Reward and Reinforcement (NCT01039454) | GlaxoSmithKline | 2008-12-18 |
| An Open Label Positron Emission Tomography (PET) Study of GSK618334 in Healthy Male Subjects Using 11C-PHNO as PET Ligand (NCT00814957) | GlaxoSmithKline | 2008-12-08 |
| Relapse Prevention Study in Newly Abstinent Smokers (NCT00793468) | GlaxoSmithKline | 2008-12-01 |
| EtOH Interaction Study (NCT00887367) | GlaxoSmithKline | 2008-09-29 |
| A Healthy Volunteer Study to Investigate the Relative Bioavailability of Two Forms of GSK598809 Capsules. (NCT00728897) | GlaxoSmithKline | 2008-07-02 |
| A Human Volunteer Study Investigating Single Oral Doses of GSK598809 in Otherwise Healthy Smokers (NCT00728052) | GlaxoSmithKline | 2008-06-09 |
| Community Reinforcement and Family Training for Drug Abuse Treatment Retention/HIV Risk Reduction (NCT00609089) | University of Cincinnati | 2008-03-01 |
| A Study To Assess The Effects Of A Single Dose Of GSK598809 In Modulating Nicotine Reward (NCT00605241) | GlaxoSmithKline | 2008-02-25 |
| A Randomized Acceptability and Safety Study of Suboxone Induction in Heroin Users (P05042)(COMPLETED) (NCT00604188) | Merck Sharp & Dohme LLC | 2008-02-22 |
| Motivational Therapy for Substance Users With Depression (NCT01189799) | University of California, Los Angeles | 2007-09-01 |
| To Investigate If Single Doses Of GSK618334 Are Safe And To Investigate Blood Levels Of GSK618334 (NCT00513279) | GlaxoSmithKline | 2007-06-28 |
| Reinforcement of Abstinence and Continuing Care in Substance Abuse Treatment (NCT00288886) | US Department of Veterans Affairs | 2007-03-01 |
| Group Therapy for Women Prisoners With Comorbid Substance Use and Depression (NCT00606996) | Brown University | 2006-07-01 |
| Randomized Trial of Ultrashort Psychotherapy vs Sustained-Release Bupropion for Smoking Cessation (NCT00484692) | Medical University Innsbruck | 2005-07-01 |
| Stress, Distress Intolerance, and Drug Dependence (NCT00430482) | Boston University Charles River Campus | 2005-06-01 |
| Behavioral Treatment of Drug Abuse in Severe and Persistent Mental Illness (SPMI) Patients (NCT00295139) | University of Maryland, Baltimore | 2005-01-01 |
| Seroquel Therapy for Substance Use Disorders Comorbid With Schizophrenia (NCT00208143) | Creighton University | 2003-11-01 |
| Modifying Group Therapy for Bipolar Substance Abusers - 1 (NCT00227838) | National Institute on Drug Abuse (NIDA) | 2003-07-01 |
| Adolescent Outpatient and Continuing Care Study (NCT01381133) | Chestnut Health Systems | 2002-09-01 |
| Improving Substance Abuse Treatment Aftercare Adherence and Outcome (NCT00057187) | US Department of Veterans Affairs | |